AzTrials
AzTrials

Health BehaviorTHRIVE-BelizeNCT07687199

THRIVE-Belize: A School-Based Life-Skills Program to Support Teen Health in Toledo District, Belize (Feasibility)

An observational study of Health Behavior and Adolescence, run by University of Arizona at 1 site in Belize.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

THRIVE-Belize is a school-based program being developed to support the health and well-being of adolescents in the Toledo District of southern Belize. The program covers seven topics: communication and emotional regulation, healthy expressions of masculinity, sexual and reproductive health, healthy relationships… Read more about this study

Who is it for?
Ages 12 years and olderHealthy volunteers can take part
Conditions the study is for
Health Behavior, Adolescence, Feasibility Studies
How many people
280 participants
Where
1 siteBelize
Study dates
Jul 2026to Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Adolescents aged 12-18 (Forms 1-4) and adult stakeholders (teachers, parents/guardians, principal and administrative staff, and community stakeholders) at one secondary school in the Toledo District, Belize.

Who may be able to join

  • Students: enrolled at Toledo Community College in Forms 1-4; ages 12-18 years; able to read and comprehend English at grade level; provides written assent; has active written parental/guardian consent
  • Teachers: currently employed at TCC; teaches students in Forms 1-4; provides written informed consent
  • Parents/Guardians: parent or legal guardian of an eligible TCC student; age 18 years or older; able to communicate in English, Spanish, or Q'eqchi'-Mopan Maya; provides written informed consent
  • School Principal and Administrative Staff: currently serving as principal or administrative staff at TCC; provides written informed consent
  • Community Stakeholders: recognized expertise in adolescent health, education, or youth services (e.g., healthcare providers, religious leaders, village council members, youth organization leaders); resident of Toledo District, Belize; provides written informed consent

Who cannot join

  • Cognitive or developmental limitations preventing informed assent or participation (students)
  • Declines to participate (students or parents/guardians)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mario Morales, PhD contact

520-645-5878

mariomorales@arizona.edu

Gabriela Valdez, PhD contact

520-626-6530

gvaldez@arizona.edu

Belize1 site
  • Toledo Community College

    Punta Gorda, Toledo District, 454V+3CH

    Shaunna Arnold Sanchez, 501 + 722-2101, tccpg@btl.net

About this study

Official title: THRIVE-Belize: A Single-School Mixed-Methods Feasibility Trial of a Multi-Component Life-Skills Curriculum for Adolescent Health Promotion at Toledo Community College, Belize

THRIVE-Belize is a school-based program being developed to support the health and well-being of adolescents in the Toledo District of southern Belize. The program covers seven topics: communication and emotional regulation, healthy expressions of masculinity, sexual and reproductive health, healthy relationships, mental and physical health, substance use prevention, and environmental health.

Before testing whether the program works, the research team needs to learn whether students, teachers, parents, school staff, and community members find it acceptable, appropriate, and practical to deliver at Toledo Community College. This study (Phase I) does not deliver the program to anyone. Instead, it gathers feedback through surveys, focus groups, and interviews with about 280 participants across these five groups.

The information collected will be used to refine the program and decide whether to move forward to a future pilot study. No medical or educational intervention is given to participants in this phase.

Keywords
feasibility study, school-based intervention, life skills, adolescents, Belize, implementation science, acceptability
Medical subject headings
Health Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07687199
Study groupRoleWhat they receive
StudentsTCC students in Forms 1-4, ages 12-18, providing feedback on the proposed curriculum via surveys, focus groups, and interviews.
TeachersTCC teachers assigned to Forms 1-4, providing feedback via surveys, focus groups, and interviews.
Parents/GuardiansParents or legal guardians of eligible TCC students, providing feedback via surveys, focus groups, and interviews.
School Principal and Administrative StaffTCC principal and administrative staff, providing feedback via surveys and interviews.
Community StakeholdersToledo District community members with expertise in adolescent health, education, or youth services, providing feedback via surveys and interviews.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of the proposed intervention (AIM)

    Mean score on the adapted 4-item Acceptability of Intervention Measure (AIM), 5-point Likert scale (1=Strongly Disagree to 5=Strongly Agree). A mean score of 4.0 or higher indicates acceptability.

    Measured: Single timepoint at post-assessment data collection (study months 1-2)

  2. Appropriateness of the proposed intervention (IAM)

    Mean score on the adapted 4-item Intervention Appropriateness Measure (IAM), 5-point Likert scale. A mean score of 4.0 or higher indicates appropriateness.

    Measured: Single timepoint at post-assessment data collection (study months 1-2)

  3. Feasibility of the proposed intervention (FIM)

    Mean score on the adapted 4-item Feasibility of Intervention Measure (FIM), 5-point Likert scale. A mean score of 4.0 or higher indicates feasibility.

    Measured: Single timepoint at post-assessment data collection (study months 1-2)

  4. Adoption and organizational readiness

    Proportion of stakeholders expressing intent to support or participate in the proposed intervention, supplemented by qualitative themes related to readiness and barriers from focus groups and interviews.

    Measured: Single timepoint at post-assessment data collection (study months 1-2)

Secondary outcomes (3)
  1. Recruitment and consent feasibility

    Consent/assent rates (target: at least 60%), retention rates, and reasons for non-participation.

    Measured: Throughout the recruitment period (study months 1-2)

  2. Measurement feasibility and respondent burden

    Survey completion rates (target: at least 90%), item-level missingness, and participant-reported comprehension of instruments.

    Measured: Single timepoint at post-assessment data collection (study months 1-2)

  3. Facilitator and delivery feasibility

    Qualitative assessment of teacher capacity, willingness to deliver the curriculum (target: at least 60% willing), training needs, and scheduling constraints.

    Measured: Single timepoint at post-assessment data collection (study months 1-2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2026
  2. Study startJul 2026 (estimated)
  3. Primary completionSep 2026 (estimated)
  4. Study completionSep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
280 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07687199
Sponsor's protocol ID
STUDY00007955
Other IDs
MOHW/IRB/2026/002, GEN/21/26(112) VOL. III
Acronym
THRIVE-Belize
Status last verified
Jul 2026
First submitted
29 Jun 2026
Last updated
7 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No public release of individual participant data (IPD) is planned due to the small sample size and potential for re-identification in a single-school setting. De-identified aggregate data may be made available upon reasonable request following primary publication, subject to University of Arizona IRB approval, Belize Ministry of Health and Wellness IRB approval, and a formal data sharing agreement.

Publications

  • Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.

    PubMed 23295957
  • Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA; PAFS consensus group. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016 Oct 24;355:i5239. doi: 10.1136/bmj.i5239.

    PubMed 27777223
  • Shinde S, Weiss HA, Varghese B, Khandeparkar P, Pereira B, Sharma A, Gupta R, Ross DA, Patton G, Patel V. Promoting school climate and health outcomes with the SEHER multi-component secondary school intervention in Bihar, India: a cluster-randomised controlled trial. Lancet. 2018 Dec 8;392(10163):2465-2477. doi: 10.1016/S0140-6736(18)31615-5. Epub 2018 Nov 22.

    PubMed 30473365
  • Patton GC, Sawyer SM, Santelli JS, Ross DA, Afifi R, Allen NB, Arora M, Azzopardi P, Baldwin W, Bonell C, Kakuma R, Kennedy E, Mahon J, McGovern T, Mokdad AH, Patel V, Petroni S, Reavley N, Taiwo K, Waldfogel J, Wickremarathne D, Barroso C, Bhutta Z, Fatusi AO, Mattoo A, Diers J, Fang J, Ferguson J, Ssewamala F, Viner RM. Our future: a Lancet commission on adolescent health and wellbeing. Lancet. 2016 Jun 11;387(10036):2423-78. doi: 10.1016/S0140-6736(16)00579-1. Epub 2016 May 9. No abstract available.

    PubMed 27174304

Questions about this trial

What is this clinical trial studying?

An observational study of Health Behavior and Adolescence, run by University of Arizona at 1 site in Belize.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belize. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mario Morales, PhD (520-645-5878, mariomorales@arizona.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of the proposed intervention (AIM) (time frame: Single timepoint at post-assessment data collection (study months 1-2)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07687199, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in